Trials / Completed
CompletedNCT02308046
Multi-Center Study of New Medications to Treat Vaginal Infections
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 212 (actual)
- Sponsor
- Curatek Pharmaceuticals, LLC · Industry
- Sex
- Female
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of terconazole gel in the treatment of vaginal infections
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Terconazole | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2014-12-04
- Last updated
- 2020-07-27
- Results posted
- 2020-07-27
Locations
41 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02308046. Inclusion in this directory is not an endorsement.